DWQA Questions › Tag: wet AMD
Filter:AllOpenResolvedClosedUnanswered
The research, recently published in JAMA Ophthalmology, found that patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—which include Ozempic, Wegovy, and Rybelsus—had more than twice the risk of developing neovascular age-related macular degeneration (nAMD), also known as “wet” AMD, a leading cause of blindness in older adults. Does GLP-1 Plus from Advanced Bionutritionals share this liability, or perhaps other downsides of those pharmaceuticals working through GLP-1 as a mechanism? What is most important for us to know?
ClosedNicola asked 3 weeks ago • 
41 views0 answers0 votes
Ask Question